JPS57132896A - Preparation of amino acid derivative - Google Patents
Preparation of amino acid derivativeInfo
- Publication number
- JPS57132896A JPS57132896A JP56019204A JP1920481A JPS57132896A JP S57132896 A JPS57132896 A JP S57132896A JP 56019204 A JP56019204 A JP 56019204A JP 1920481 A JP1920481 A JP 1920481A JP S57132896 A JPS57132896 A JP S57132896A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- amino acid
- glutamylcysteine synthetase
- glutamic acid
- acid derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003862 amino acid derivatives Chemical class 0.000 title abstract 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical group OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 abstract 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 4
- 108010081687 Glutamate-cysteine ligase Proteins 0.000 abstract 3
- 102100033398 Glutamate-cysteine ligase regulatory subunit Human genes 0.000 abstract 3
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 abstract 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-Glutamic acid Natural products OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 2
- FSBIGDSBMBYOPN-VKHMYHEASA-N L-canavanine Chemical compound OC(=O)[C@@H](N)CCONC(N)=N FSBIGDSBMBYOPN-VKHMYHEASA-N 0.000 abstract 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Chemical group OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 abstract 2
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229960002989 glutamic acid Drugs 0.000 abstract 2
- 229960003080 taurine Drugs 0.000 abstract 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- LRQKBLKVPFOOQJ-UHFFFAOYSA-N 2-aminohexanoic acid Chemical compound CCCCC(N)C(O)=O LRQKBLKVPFOOQJ-UHFFFAOYSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 abstract 1
- 229930182847 D-glutamic acid Natural products 0.000 abstract 1
- 241000588722 Escherichia Species 0.000 abstract 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- FSBIGDSBMBYOPN-UHFFFAOYSA-N O-guanidino-DL-homoserine Natural products OC(=O)C(N)CCON=C(N)N FSBIGDSBMBYOPN-UHFFFAOYSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- 241000589516 Pseudomonas Species 0.000 abstract 1
- 229960005261 aspartic acid Drugs 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56019204A JPS57132896A (en) | 1981-02-12 | 1981-02-12 | Preparation of amino acid derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56019204A JPS57132896A (en) | 1981-02-12 | 1981-02-12 | Preparation of amino acid derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57132896A true JPS57132896A (en) | 1982-08-17 |
| JPH0141315B2 JPH0141315B2 (enrdf_load_stackoverflow) | 1989-09-05 |
Family
ID=11992823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56019204A Granted JPS57132896A (en) | 1981-02-12 | 1981-02-12 | Preparation of amino acid derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57132896A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006121055A1 (ja) * | 2005-05-09 | 2006-11-16 | Kyowa Hakko Kogyo Co., Ltd. | γ-グルタミルアミド化合物の製造方法 |
| JP2022534374A (ja) * | 2019-05-20 | 2022-07-29 | ワッカー ケミー アクチエンゲゼルシャフト | γ－グルタミルチロシン及びγ－グルタミルフェニルアラニンを発酵生産する微生物の株及び方法 |
-
1981
- 1981-02-12 JP JP56019204A patent/JPS57132896A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006121055A1 (ja) * | 2005-05-09 | 2006-11-16 | Kyowa Hakko Kogyo Co., Ltd. | γ-グルタミルアミド化合物の製造方法 |
| JP2022534374A (ja) * | 2019-05-20 | 2022-07-29 | ワッカー ケミー アクチエンゲゼルシャフト | γ－グルタミルチロシン及びγ－グルタミルフェニルアラニンを発酵生産する微生物の株及び方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0141315B2 (enrdf_load_stackoverflow) | 1989-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thorne et al. | Transamination of D-amino acids by Bacillus subtilis | |
| Herrmann | The common aromatic biosynthetic pathway. | |
| WO1994015488A3 (en) | Rehydration drink | |
| DE3679396D1 (de) | Synthetisches peptid mit menschlicher interleukin 1-wirksamkeit. | |
| SE9402156L (sv) | Farmaceutiska kompositioner innehållande salterna av s(+)-2- (4-isobutylfenyl)-propionsyra med basiska aminosyror | |
| EP0464325A3 (en) | Process for the preparation of l-ornithine salts | |
| SE7909497L (sv) | Aminosyrasalt | |
| JPS57132896A (en) | Preparation of amino acid derivative | |
| JPS5626196A (en) | Preparation of l-aspartic acid | |
| JPS5486635A (en) | First liquid of cold-wave lotion | |
| JPS56110661A (en) | Preparation of n-benzyloxycarbonyl-l-aspartic acid | |
| JPS57209211A (en) | Antimicrobial composition | |
| EP0267179A3 (en) | Cystin compounds, their preparation and their use | |
| Ta et al. | Utilization of the amide groups of asparagine and 2-hydroxysuccinamic acid by young pea leaves | |
| Neumann et al. | Poly-α-amino-acids containing L-Glutamyl Residues as Substrates for Pepsin | |
| Miyazaki et al. | Crystalline serine hydroxymethyltransferase from an obligate methylotroph, Hyphomicrobium methylovorum | |
| WINITZ et al. | Quantitative nutritional and in vivo metabolic studies with water-soluble, chemically defined diets | |
| Kamath et al. | Antagonism of the D-forms of the essential amino acids toward the promotion of growth by D-histidine | |
| Welbourne et al. | Glutamate transport and not cellular content modulates paracellular permeability in LLC-PK1-F+ cells | |
| JPS5681515A (en) | Amino acid transfusion | |
| Sahulka | The regulation of the synthesis of glutamate dehydrogenase in excised pea roots by exogenous L-aspartic and L-glutamic acids | |
| Durham et al. | Relationship of a β-alanine-pyruvic aminotransferase to reversal of D-serine inhibition of growth | |
| JPS57132882A (en) | Preparation of l-alanine and d-aspartic acid | |
| JPS6447707A (en) | Cosmetic | |
| Erlandson Jr et al. | Oxidative dissimilation of amino acids and related compounds by Shigella flexneri |